Erectile dysfunction and hypogonadism among men with HIV

Area of Science:

• Endocrinology
• Infectious Diseases
• Urology

Background:

• Erectile dysfunction (ED) and hypogonadism are common conditions, but their prevalence and causes in men with HIV are not well understood.
• Understanding these conditions is crucial for improving the sexual health and overall well-being of HIV-infected individuals.

Purpose of the Study:

• To determine the prevalence and identify the risk factors for erectile dysfunction (ED) and hypogonadism in a cohort of HIV-infected men.
• To investigate the relationship between ED, hypogonadism, and HIV-related factors, including antiretroviral therapy and CD4 count.

Main Methods:

• A cross-sectional study of 300 HIV-infected men using standardized questionnaires for sexual function and hypogonadal symptoms.
• Early morning serum testosterone levels were measured; low testosterone (<300 ng/dL) prompted further tests to determine the cause of hypogonadism.
• Multivariate analysis was used to identify factors associated with ED and hypogonadism.

Main Results:

• Erectile dysfunction (ED) was reported by 61.4% of participants. Increasing age and depression were significantly associated with ED, while a higher CD4 count was protective.
• Seventeen percent of men were hypogonadal, with secondary hypogonadism identified in all cases. Increasing age and BMI were associated with hypogonadism; smoking showed a protective association.
• No correlation was found between ED and hypogonadism. Neither condition was associated with the use of HIV medications.

Conclusions:

• Erectile dysfunction (ED) is highly prevalent in HIV-infected men and is associated with aging, depression, and lower CD4 counts.
• Hypogonadism is also prevalent and linked to aging and BMI, but it is independent of ED and HIV medication use.
• Targeted screening and management strategies for ED and hypogonadism should be considered in HIV-infected men, particularly older individuals and those with depression.